Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma

We report on 12 consecutive patients with advanced/metastatic Ewing's sarcoma who were treated as a separate cohort of a phase 1 trial of FANG autologous immunotherapy (1 × 10(6)–2.5 × 10(7) cells/intradermal injection each month for minimum 4 months). Safety and clinical response were monitore...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghisoli, Maurizio, Barve, Minal, Schneider, Reva, Mennel, Robert, Lenarsky, Carl, Wallraven, Gladice, Pappen, Beena O, LaNoue, John, Kumar, Padmasini, Nemunaitis, Derek, Roth, Alyssa, Nemunaitis, James, Whiting, Sam, Senzer, Neil, Fletcher, Frederick A, Nemunaitis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817748/
https://www.ncbi.nlm.nih.gov/pubmed/25917459
http://dx.doi.org/10.1038/mt.2015.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817748/
https://www.ncbi.nlm.nih.gov/pubmed/25917459
http://dx.doi.org/10.1038/mt.2015.43

Ejemplares similares